Applied Nutrition plc has reported record half-year results 18 months after it floated in London.
The Liverpool firm was founded by fitness enthusiast Thomas Ryder in 2014 and went public in October 2024. Wayne Rooney’s wife Coleen recently increased her shareholding in the sports nutrition, health and wellness brand.
For the six months ended 31st January 2026, Applied Nutrition reported revenues of £74.5 million, an increase of 56.5%, while statutory profit before tax was £20.9m – a jump of 77.1%. Adjusted EBITDA was £21.5m, up 55.8%.
In the period Applied Nutrition said it deepened relationships with existing customers through increased shelf space and distribution, particularly across UK high street retailers and discounters such as B&M.
It secured a first out-licensing agreement with Morrisons, further extending its brand into mainstream grocery with a new range of high‑protein food products, while it also continued the extension of its global footprint across key regions in Europe, Latin America and Asia.
New products and formats launched in the period included a 40+ range, Slush Puppie ABE collaboration and expanded creatine offerings.
Applied Nutrition recently secured planning permission from Knowsley Council for a new 84,000 sq ft global distribution centre and corporate headquarters. This will take its total operational footprint to over 204,000 sq ft and increase revenue capability to £300m, it said.
The firm acknowledged the current disruption to shipping routes and purchasing activities within the Middle East. “Although we expect some reduction in volumes into the region during the second half, at this stage there is no change to FY26 guidance of full year revenue of approximately £140m,” it said.
Ryder said: “Our vision to become the world’s most trusted and innovative sports nutrition, health, and wellness brand remains at the heart of our ambition.
“This six-month period has further highlighted both the breadth of opportunity before us and our proven ability to realise it. The performance and momentum across the business reflects a consumer environment that continues to shift decisively towards health, fitness and wellbeing.
“We have continued to execute against our strategic priorities in the period, with deeper engagement and expanded shelf space with existing customers, new customer wins and entry into new channels, continued international rollout into new geographies, while further progressing the build-out of our D2C offering.
“Since our IPO, we have seen an uplift in our profile, awareness, trust and credibility – exactly as we had envisaged, but even more impactful than we could have anticipated.
“This has enabled us to move faster and think bigger, with an innovation engine that is stronger than ever, allowing us to bring new products to market at pace, deepen customer relationships and adapt quickly to evolving consumer needs as we continue to build the business for the long term.”
Before trading commences this week, its shares are valued at 221 pence, with a market cap of £552.5m. The current share price is down 14% in the year to date but up 82% in the last year and 64% on its IPO price.